Hypothesis: β amyloid precursor protein is a key sorting and targeting receptor for neuropeptidases

Amyloid

Volumn 4, Issue 4, 1997, Pages 233-239

  Fine, Richard E ^a,b   Abraham, Carmela R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Secretase; Synaptic transmission, neuropeptides, protease

Indexed keywords

EID: 0344991838     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129709003834     Document Type: Article

References (39)

1. Morin PJ, Abraham CR, Amaratunga A, Johnson R J, Huber G, Sandell JH and Fine RE (1993). Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized J Neurochem 61, 464-473
2. Van Nostrand W, Schmaier A, Farrow J and Cunningham DD (1990). Protease nexin II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 248, 745-748
3. Amaratunga A and Fine RE (1995). Generation of amyloidogenic c-terminal fragments during rapid axonal transport in vivo of β-amyloid precursor protein in the optic nerve. J Biol Chem 270, 17268-17272
4. Haass C, Hung AY and Selkoe DJ (1991). Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 11, 3783-3793
5. Morin PJ, Liu N, Johnson RJ, Leeman SE and Fine RE (1991). Isolation and characterization of rapid transport vesicle subtypes from rabbit optic nerve. J Neurochem 56, 415-427
6. Simons M, Ikonen E, Tienari PJ, Cid-Arregui A, Monning U, Beyreuther K and Dotti CG (1995). Intracellular routing of human amyloid precursor: axonal delivery followed by transport to the dendrites. J Neurosci Res 41, 121-128
7. Yamazaki T, Selkoe DJ and Koo EH (1995). Trafficking of cell surface β amyloid precursor protein: Retrograde and transcytotic transport in cultured neurons. J Cell Biol 129, 431-442
8. Koo EH, Sisodia SS, Archer DA, Martin LJ, Weidemann A, Beyreuther K, Fisher P, Masters CL and Price DL (1990). Precursor of amyloid protein in Alzheimer's disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87, 1561-1565
9. Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TY, Unterbeck AJ and Greengard P (1990). Processing of Alzheimer β-A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87, 6003-6006
10. Nitsch R, Slack B, Wurtman R and Growdon J (1992). Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307
11. Farber SA, Nitsch RM, Schulz JG and Wurtman RJ (1995). Regulated secretion of β-amyloid precursor protein in rat brain. J Neurosci 15, 7442-7451
12. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Olterdorf T, McClure D and Ward PJ (1990). Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 492-495
13. Allinquant B, Hantraye P, Mailleux P, Moya K, Bouillot C and Prochiantz A (1995). Down regulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol 128, 919-927
14. Kibbey MC, Jucker M, Weeks BS, Neve RL, Van Nostrand WE and Kleinman HK (1993). β-Amyloid precursor protein binds to the neurite-promoting IKVAY site of laminin. Proc Natl Acad Sci USA 90, 10150-10153
15. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Human BT and Strickland DK (1995). LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340
16. Haass C, Koo EH, Mellon A, Hung AY and Selkoe DJ (1992). Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid bearing fragments. Nature 357, 500-503
17. Nordstedt C, Caporaso GL, Thyberg J, Gandy, SE and Greengard P (1993). Identification of the Alzheimer β/A4 amyloid pecursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem 268, 608-612
18. Papastoitis G, Siman R, Scott R, and Abraham CR (1994). Identification of metalloproteases from AD brain able to degrade the β-APP and generate amyloidogenic fragments. Biochemistry 33, 192-199
19. Chang T and Abraham CR (1996). A novel brain cysteine protease forms an SDS stable complex with the β-amyloid precursor protein. Ann NY Acad Sci 777, 183-188
20. Razzaboni BL, Papastoitsis P, Koo E and Abraham CR (1992). A calcium stimulated serine protease from monkey brain degrades the β-amyloid precursor protein. Brain Res 589, 207-216
21. Abraham CR, Driscoll J, Potter H, Van Nostrand WE and Tempst P (1991). A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid B-protein. Biochem Biophys Res Comin 174, 790-796
22. Van Nostrand W E, Wagner S L, Farrow JS and Cunningham DD (1990). Immunopurification and potease inhibitory properties of protease nexin-2/amyloid β-protein precursor. J Biol Chem 265, 9591-9594
23. Selkoe DJ (1994). Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease. Current Opinion in Neurobiology 4, 708-716
24. Citron M, Oltersdorf T, Haas C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, and Selkoe DJ (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's Disease increases β-protein production. Nature 360, 672-674
25. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos Jr L, Eckman C, Golde TE, and Younkin SG (1994). An increased percentage of long amyloid β-protein secreted by familial amyloid βprotein precursor (βAPP717) mutants. Science 264, 1336-1340
26. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda, T, Mar I, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM and St George-Hyslop PH (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760
27. Levy-Lahad E, Wasco W, Poorkay P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y- H, Guenette SY, Galas D, Nemens E, Wijsman, E.M., Bird, T.D., Schellenberg, G.D., and Tanzi, R.E. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-981
28. Levitan D and Greenwald I (1995). Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354
29. Scheuner D, Song X, Suzuki N, Bird TD, Citron M, Hardy J, Huutton M, Lannfelt L, Peskind ER, Schellenberg GD, Selkoe DJ, Tanzi RE, Viitanen M, Wasco W, and Younkin S (1995). Fibroblasts from carriers of familial AD linked to chromosome 14 show increased Aβ production. Soc Neurosci 21, 1500
30. Kovacs DM, Fausett H, Page KJ, Kim T-W, Moir RD, Merriam DE, Hollister RD, Hollmark OG, Mancini R, Felsenstein KM, Hyman BT, Tanzi RE, and Wasco W (1996). Alzheimer- associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Medicine 2, 16
31. Kelly R (1993). Storage and release of neurotransmitters. Cell 72, 43-53
32. Meckelein B, de Silva HAR, Roses AD, Rao PN, Pettenati MJ, Xu PT, Hodge R, Glucksman MJ and Abraham CR (1996). Human endopeptidase E.C.3.4.24.15 (THOP 1) is localized on chromosome 19 within the linkage region for late-onset Alzheimer's disease AD2 locus. Genomics 31, 246-249
33. Strittmatter WJ and Roses AD (1995). Apolipoprotein E and Alzheimer's disease. Proc. Natl Acad Sci USA 92, 4725-4727
34. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, and Pericak-Vance MA (1993). Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's Disease in late onset families. Science 261, 921-923
35. Farrer LA, Abraham CR, Volicer L, Foley EJ, Kowall NW, McKee AC and Wells JM (1995). Allele 4 of apolipoprotein E is associated with Pick disease and shows a dose effect on age at onset. Exp Neurol 136, 162-170
36. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, and Roses AD (1993). Apolipoprotein E: high avidity binding to β amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90, 1977-1981
37. Amaratunga A, Abraham CR, Edwards RB, Sandell JH, Schreiber BM and Fine RE (1996). Apolipoprotein E is synthesized in the retina by Muller Glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J Biol Chem 271, 5628-5632
38. Nathan BP, Bellosta S, Sanan DA, Weisgraber K., Mahley RW and Pitas RE (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852
39. Nathan BP, Chang K-C, Bellosta S, Brisch E, Ge N, Mahley RW and Pitas RE (1995). The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270, 19791-19799